Voyageur Pharmaceuticals Stock Probability of Future Stock Price Finishing Over 0.065

VM Stock  CAD 0.05  0.01  9.09%   
Voyageur Pharmaceuticals' future price is the expected price of Voyageur Pharmaceuticals instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Voyageur Pharmaceuticals performance during a given time horizon utilizing its historical volatility. Check out Voyageur Pharmaceuticals Backtesting, Voyageur Pharmaceuticals Valuation, Voyageur Pharmaceuticals Correlation, Voyageur Pharmaceuticals Hype Analysis, Voyageur Pharmaceuticals Volatility, Voyageur Pharmaceuticals History as well as Voyageur Pharmaceuticals Performance.
  
Price Earnings Ratio is likely to drop to -2.02 in 2024. Price Book Value Ratio is likely to drop to 0.14 in 2024. Please specify Voyageur Pharmaceuticals' target price for which you would like Voyageur Pharmaceuticals odds to be computed.

Voyageur Pharmaceuticals Target Price Odds to finish over 0.065

The tendency of Voyageur Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move over C$ 0.07  or more in 90 days
 0.05 90 days 0.07 
about 70.3
Based on a normal probability distribution, the odds of Voyageur Pharmaceuticals to move over C$ 0.07  or more in 90 days from now is about 70.3 (This Voyageur Pharmaceuticals probability density function shows the probability of Voyageur Stock to fall within a particular range of prices over 90 days) . Probability of Voyageur Pharmaceuticals price to stay between its current price of C$ 0.05  and C$ 0.07  at the end of the 90-day period is about 28.3 .
Given the investment horizon of 90 days the stock has the beta coefficient of 1.11 . This entails Voyageur Pharmaceuticals market returns are correlated to returns on the market. As the market goes up or down, Voyageur Pharmaceuticals is expected to follow. Additionally Voyageur Pharmaceuticals has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
   Voyageur Pharmaceuticals Price Density   
       Price  

Predictive Modules for Voyageur Pharmaceuticals

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Voyageur Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Voyageur Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.000.057.37
Details
Intrinsic
Valuation
LowRealHigh
0.000.057.37
Details
Naive
Forecast
LowNextHigh
0.0010.057.37
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.050.060.08
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Voyageur Pharmaceuticals. Your research has to be compared to or analyzed against Voyageur Pharmaceuticals' peers to derive any actionable benefits. When done correctly, Voyageur Pharmaceuticals' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Voyageur Pharmaceuticals.

Voyageur Pharmaceuticals Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Voyageur Pharmaceuticals is not an exception. The market had few large corrections towards the Voyageur Pharmaceuticals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Voyageur Pharmaceuticals, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Voyageur Pharmaceuticals within the framework of very fundamental risk indicators.
α
Alpha over NYSE Composite
-0.54
β
Beta against NYSE Composite1.11
σ
Overall volatility
0.01
Ir
Information ratio -0.07

Voyageur Pharmaceuticals Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Voyageur Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Voyageur Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Voyageur Pharmaceuticals generated a negative expected return over the last 90 days
Voyageur Pharmaceuticals has high historical volatility and very poor performance
Voyageur Pharmaceuticals has some characteristics of a very speculative penny stock
The company currently holds 40 K in liabilities with Debt to Equity (D/E) ratio of 28.1, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Voyageur Pharmaceuticals has a current ratio of 0.16, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Voyageur Pharmaceuticals until it has trouble settling it off, either with new capital or with free cash flow. So, Voyageur Pharmaceuticals' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Voyageur Pharmaceuticals sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Voyageur to invest in growth at high rates of return. When we think about Voyageur Pharmaceuticals' use of debt, we should always consider it together with cash and equity.
Net Loss for the year was (1.4 M) with profit before overhead, payroll, taxes, and interest of 0.
Voyageur Pharmaceuticals currently holds about 27.59 K in cash with (991.25 K) of positive cash flow from operations.
Latest headline from news.google.com: Closing Bell Voyageur Pharmaceuticals Ltd up on Wednesday - The Globe and Mail

Voyageur Pharmaceuticals Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Voyageur Stock often depends not only on the future outlook of the current and potential Voyageur Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Voyageur Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding130.5 M
Cash And Short Term Investments2085.00

Voyageur Pharmaceuticals Technical Analysis

Voyageur Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. Voyageur Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Voyageur Pharmaceuticals. In general, you should focus on analyzing Voyageur Stock price patterns and their correlations with different microeconomic environments and drivers.

Voyageur Pharmaceuticals Predictive Forecast Models

Voyageur Pharmaceuticals' time-series forecasting models is one of many Voyageur Pharmaceuticals' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Voyageur Pharmaceuticals' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Voyageur Pharmaceuticals

Checking the ongoing alerts about Voyageur Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Voyageur Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Voyageur Pharmaceuticals generated a negative expected return over the last 90 days
Voyageur Pharmaceuticals has high historical volatility and very poor performance
Voyageur Pharmaceuticals has some characteristics of a very speculative penny stock
The company currently holds 40 K in liabilities with Debt to Equity (D/E) ratio of 28.1, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Voyageur Pharmaceuticals has a current ratio of 0.16, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Voyageur Pharmaceuticals until it has trouble settling it off, either with new capital or with free cash flow. So, Voyageur Pharmaceuticals' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Voyageur Pharmaceuticals sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Voyageur to invest in growth at high rates of return. When we think about Voyageur Pharmaceuticals' use of debt, we should always consider it together with cash and equity.
Net Loss for the year was (1.4 M) with profit before overhead, payroll, taxes, and interest of 0.
Voyageur Pharmaceuticals currently holds about 27.59 K in cash with (991.25 K) of positive cash flow from operations.
Latest headline from news.google.com: Closing Bell Voyageur Pharmaceuticals Ltd up on Wednesday - The Globe and Mail

Complementary Tools for Voyageur Stock analysis

When running Voyageur Pharmaceuticals' price analysis, check to measure Voyageur Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Voyageur Pharmaceuticals is operating at the current time. Most of Voyageur Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Voyageur Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Voyageur Pharmaceuticals' price. Additionally, you may evaluate how the addition of Voyageur Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Please note, there is a significant difference between Voyageur Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Voyageur Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Voyageur Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.